OptiNose Q4 GAAP EPS $(0.09), Inline, Sales $19.86M Beat $19.23M Estimate
Portfolio Pulse from Benzinga Newsdesk
OptiNose (NASDAQ:OPTN) reported Q4 GAAP EPS of $(0.09), meeting analyst consensus estimates and marking a 47.06% improvement over last year's $(0.17) per share. Quarterly sales reached $19.86M, surpassing the $19.23M estimate but showing a 4.75% decrease from the previous year.
March 07, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OptiNose reported a Q4 GAAP EPS of $(0.09), in line with estimates, and a 47.06% improvement YOY. Sales of $19.86M exceeded expectations but were down 4.75% YOY.
The EPS meeting estimates and the sales beating expectations, despite a YOY decrease, suggest a positive short-term impact on OPTN's stock price. The improvement in EPS YOY indicates operational efficiency or cost management, which could be viewed favorably by investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100